Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic (FIAT)

NCT05291897 is registered in ClinicalTrials.gov with Angelini Pharma Česká republika s.r.o. as lead sponsor.

NCT NCT05291897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05291897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First choIce Antidepressants: General Practitioner's Treatment Approach in the Czech Republic (FIAT)
Lead sponsor
Angelini Pharma Česká republika s.r.o.
Phase
Observational
Overall status
Terminated
Start date
October 15, 2021
Completion date
June 30, 2023
Enrollment
28 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

adult patients, major depressive disorder co-occurrent with anxiety, newly diagnosed depression